SB 477 (2026)
Establish reporting related to 340B Drug Pricing Program, prevent duplicate discounts
This bill is still active.
Establishes reporting requirementsrelated to the 340B Drug Pricing Program, which requires drug manufacturers to sell outpatient drugs at discounted prices at some hospitals for those drugs to be covered by Medicaid. The bill then requires the Department of Health and Human Services (DHHS) to require 340B identifiers across claims, and implement rules to prevent duplicate discounts.
The data you see here is pulled daily from official government databases. The bill summary is created by Citizens Count staff. Learn more about our methodology for summarizing and updating bills. Visit the official New Hampshire government website for a deep-dive on this bill.
